Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis.

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Glioblastoma, an aggressive form of brain cancer, originates in the brain's supportive tissue, known as glial cells. It is ...

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

A book takes readers on a journey through the history of neurosurgery, and how it's done, by the very best tour guide ...

Discover how the antidepressant vortioxetine may offer new hope in fighting aggressive brain tumours like glioblastoma ...

for treating brain tumors called IDH-mutant low-grade gliomas (LGGs). Their research raises significant concerns about the approval process and the drug's actual benefits for patients. LGGs are a ...

An eight-year-old boy has completed a 50-mile (80km) cycling and climbing challenge in memory of his best friend who died ...

Sun Pharma has signed a global licensing deal with Philogen to commercialize Fibromun, an anti-cancer treatment currently in ...